Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice

Journal of Neuroimmunology

Volumn 179, Issue 1-2, 2006, Pages 26-36

  Ma, Xiaoxing ^a   Foster, Jane ^a,b   Sakic, Boris ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b Brain Body Institute   (Canada)

Author keywords

Autoimmunity; B cells; Cerebellum; Choroid plexus; Flow cytometry; Hippocampus; Immunohistochemistry; Lupus; MRL mice; Neurodegeneration; Plasma cells; T cells

Indexed keywords

AUTOANTIBODY; CD19 ANTIGEN; CD3 ANTIGEN; IMMUNOGLOBULIN M; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN; BRAIN ATROPHY; BRAIN GROWTH; CELL INFILTRATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEUKOCYTE; MALE; MONONUCLEAR CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PLASMA CELL; PREVALENCE; PRIORITY JOURNAL; SPLENOMEGALY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD19; ANTIGENS, CD3; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED MRL LPR; PHENOTYPE; PLASMA CELLS; RNA, MESSENGER; SYNDECAN-1; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748964612     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.06.023     Document Type: Article

References (69)

1. Alexander E.L., Murphy E.D., Roths J.B., and Alexander G.E. Congenic autoimmune murine models of central nervous system disease in connective tissue disorders. Ann. Neurol. 14 (1983) 242-248
2. Alexander J.J., Jacob A., Bao L., Macdonald R.L., and Quigg R.J. Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis. J. Immunol. 175 (2005) 8312-8319
3. Allan S.M., and Rothwell N.J. Cytokines and acute neurodegeneration. Nat. Rev., Neurosci. 2 (2001) 734-744
4. Ballok D.A., and Sakic B. Neurodegeneration in autoimmune mice as revealed by Fluoro Jade B (Abstract). Soc. Neurosci. 93 (2002) 15
5. Ballok D.A., Millward J.M., and Sakic B. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Brain Res. 964 (2003) 200-210
6. Ballok D.A., Szechtman H., and Sakic B. Taste responsiveness and diet preference in autoimmune MRL mice. Behav. Brain Res. 140 (2003) 119-130
7. Ballok D.A., Woulfe J., Sur M., Cyr M., and Sakic B. Hippocampal damage in mouse and human forms of systemic autoimmune disease. Hippocampus 14 (2004) 649-661
8. Ballok, D.A., Ma, X., Denburg, J.A., Arsenault, L., Sakic, B., in press. Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus. J. Rheumatol.
9. Bluestein H.G., and Woods V.L. Antineuronal antibodies in systemic lupus erythematosus. Arthritis Rheum. 25 (1982) 773-778
10. Brey R.L., Holliday S.L., Saklad A.R., Navarrete M.G., Hermosillo-Romo D., Stallworth C.L., Valdez C.R., Escalante A., del R. I., Gronseth G., Rhine C.B., Padilla P., and McGlasson D. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58 (2002) 1214-1220
11. Call M.E., Pyrdol J., Wiedmann M., and Wucherpfennig K.W. The organizing principle in the formation of the T cell receptor-CD3 complex. Cell 111 (2002) 967-979
12. Crimando J., and Hoffman S.A. Detection of brain-reactive autoantibodies in the sera of autoimmune mice using ELISA. J. Immunol. Methods 149 (1992) 87-95
13. Crimando J., and Hoffman S.A. Characterization of murine brain-reactive monoclonal IgG autoantibodies. Brain Behav. Immun. 9 (1995) 165-181
14. Culton D.A., O'Conner B.P., Conway K.L., Diz R., Rutan J., Vilen B.J., and Clarke S.H. Early preplasma cells define a tolerance checkpoint for autoreactive B cells. J. Immunol. 176 (2006) 790-802
15. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., and Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7 (2001) 1189-1193
16. Denburg S.D., and Denburg J.A. Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus. Lupus 12 (2003) 883-890
17. Denenberg V.H., Sherman G.F., Rosen G.D., Morrison L., Behan P.O., and Galaburda A.M. A behavior profile of the MRL/Mp lpr/lpr mouse and its association with hydrocephalus. Brain Behav. Immun. 6 (1992) 40-49
18. Downen M., Amaral T.D., Hua L.L., Zhao M.L., and Lee S.C. Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha. Glia 28 (1999) 114-127
19. Engelhardt B., Wolburg-Buchholz K., and Wolburg H. Involvement of the choroid plexus in central nervous system inflammation. Microsc. Res. Tech. 52 (2001) 112-129
20. Farrell M., Sakic B., Szechtman H., and Denburg J.A. Effect of cyclophosphamide on leucocytic infiltration in the brain of MRL/lpr mice. Lupus 6 (1997) 268-274
21. Foster J.A., Puchowicz M.J., McIntyre D.C., and Herkenham M. Activin mRNA induced during amygdala kindling shows a spatiotemporal progression that tracks the spread of seizures. J. Comp. Neurol. 476 (2004) 91-102
22. Giuliani F., Goodyer C.G., Antel J.P., and Yong V.W. Vulnerability of human neurons to T cell-mediated cytotoxicity. J. Immunol. 171 (2003) 368-379
23. Hanly J.G. Neuropsychiatric lupus. Curr. Rheumatol. Rep. 3 (2001) 205-212
24. Hess D.C., Taormina M., Thompson J., Sethi K.D., Diamond B., Rao R., and Feldman D.S. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J. Rheumatol. 20 (1993) 610-617
25. Hickey W.F. Basic principles of immunological surveillance of the normal central nervous system. Glia 36 (2001) 118-124
26. Hickey W.F., Hsu B.L., and Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28 (1991) 254-260
27. Hirohata S., Hirose S., and Miyamoto T. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity. Arch. Intern. Med. 145 (1985) 1843-1846
28. Hoffman S.A., and Harbeck R.J. CNS lupus and the blood-brain barrier. In: Neuwelt E.A. (Ed). Implications of the Blood-Brain Barrier and Its Manipulation (1989), Plenum Medical Book Co., New York-London 469-494
29. Hoffman S.A., and Madsen C.S. Brain specific autoantibodies in murine models of systemic lupus erythematosus. J. Neuroimmunol. 30 (1990) 229-237
30. Hoffman S.A., Arbogast D.N., Day T.T., Shucard D.W., and Harbeck R.J. Permeability of the blood cerebrospinal fluid barrier during acute immune complex disease. J. Immunol. 130 (1983) 1695-1698
31. Huerta P.T., Kowal C., DeGiorgio L.A., Volpe B.T., and Diamond B. Immunity and behavior: antibodies alter emotion. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 678-683
32. James W.G., Bullard D.C., and Hickey M.J. Critical role of the alpha 4 integrin/VCAM-1 pathway in cerebral leukocyte trafficking in lupus-prone MRL/fas(lpr) mice. J. Immunol. 170 (2003) 520-527
33. Jongen P.J., Doesburg W.H., Ibrahim-Stappers J.L., Lemmens W.A., Hommes O.R., and Lamers K.J. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system. Acta Neurol. Scand. 101 (2000) 116-121
34. Khin N.A., and Hoffman S.A. Brain reactive monoclonal auto-antibodies: production and characterization. J. Neuroimmunol. 44 (1993) 137-148
35. Kowal C., DeGiorgio L.A., Nakaoka T., Hetherington H., Huerta P.T., Diamond B., and Volpe B.T. Cognition and immunity; antibody impairs memory. Immunity 21 (2004) 179-188
36. Lindsley M.D., and Rodriguez M. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J. Immunol. 142 (1989) 2677-2682
37. Luzina I.G., Knitzer R.H., Atamas S.P., Gause W.C., Papadimitriou J.C., Sztein M.B., Storrer C.E., and Handwerger B.S. Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells. Arthritis Rheum. 42 (1999) 561-568
38. Maric D., Millward J.M., Ballok D.A., Szechtman H., Barker J.L., Denburg J.A., and Sakic B. Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice. Brain Res. 920 (2001) 183-193
39. McCarron R.M., Wang L., Racke M.K., McFarlin D.E., and Spatz M. Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 43 (1993) 23-30
40. McHale J.F., Harari O.A., Marshall D., and Haskard D.O. TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. J. Immunol. 163 (1999) 3993-4000
41. McLean B.N., Miller D., and Thompson E.J. Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet's disease involving the nervous system. J. Neurol. Neurosurg. Psychiatry 58 (1995) 548-554
42. Narendran A., and Hoffman S.A. Characterization of brain-reactive autoantibodies in murine models of systemic lupus erythematosus. J. Neuroimmunol. 24 (1989) 113-123
43. Nikolic T., Dingjan G.M., Leenen P.J., and Hendriks R.W. A subfraction of B220(+) cells in murine bone marrow and spleen does not belong to the B cell lineage but has dendritic cell characteristics. Eur. J. Immunol. 32 (2002) 686-692
44. Sakic B., Szechtman H., Keffer M., Talangbayan H., Stead R., and Denburg J.A. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav. Immun. 6 (1992) 265-285
45. Sakic B., Szechtman H., Denburg S.D., Carbotte R.M., and Denburg J.A. Spatial learning during the course of autoimmune disease in MRL mice. Behav. Brain Res. 54 (1993) 57-66
46. Sakic B., Szechtman H., Talangbayan H., Denburg S.D., Carbotte R.M., and Denburg J.A. Disturbed emotionality in autoimmune MRL-lpr mice. Physiol. Behav. 56 (1994) 609-617
47. Sakic B., Denburg J.A., Denburg S.D., and Szechtman H. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Res. Bull. 41 (1996) 305-311
48. Sakic B., Szechtman H., and Denburg J.A. Neurobehavioral alteration in autoimmune mice. Neurosci. Biobehav. Rev. 21 (1997) 327-340
49. Sakic B., Szechtman H., Denburg J.A., Gorny G., Kolb B., and Whishaw I.Q. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. J. Neuroimmunol. 87 (1998) 162-170
50. Sakic B., Maric I., Koeberle P.D., Millward J.M., Szechtman H., Maric D., and Denburg J.A. Increased TUNEL-staining in brains of autoimmune Fas-deficient mice. J. Neuroimmunol. 104 (2000) 147-154
51. Sakic B., Hanna S.E., and Millward J.M. Behavioral heterogeneity in an animal model of neuropsychiatric lupus. Biol. Psychiatry 57 (2005) 679-687
52. Sanderson R.D., Lalor P., and Bernfield M. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul. 1 (1989) 27-35
53. Sato S., Steeber D.A., and Tedder T.F. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 11558-11562
54. Sidor M.M., Sakic B., Malinowski P.M., Ballok D.A., Oleschuk C.J., and Macri J. Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice. J. Neuroimmunol. 165 (2005) 104-113
55. Svenungsson E., Andersson M., Brundin L., van Vollenhoven R., Khademi M., Tarkowski A., Greitz D., Dahlstrom M., Lundberg I., Klareskog L., and Olsson T. Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann. Rheum. Dis. 60 (2001) 372-379
56. Theofilopoulos A.N. Murine models of lupus. In: Lahita R.G. (Ed). Systemic Lupus Erythematosus (1992), Churchill Livingstone, New York 121-194
57. Tomita M., Holman B.J., and Santoro T.J. Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci. Lett. 302 (2001) 129-132
58. Tomita M., Holman B.J., Williams L.S., Pang K.C., and Santoro T.J. Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus. J. Neurosci. Res. 64 (2001) 26-33
59. Trysberg E., Nylen K., Rosengren L.E., and Tarkowski A. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum. 48 (2003) 2881-2887
60. Trysberg E., Blennow K., Zachrisson O., and Tarkowski A. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement. Arthritis Res. Ther. 6 (2004) R551-R556
61. Vilhardt F. Microglia: phagocyte and glia cell. Int. J. Biochem. Cell Biol. 37 (2005) 17-21
62. Vogelweid C.M., Johnson G.C., Besch-Williford C.L., Basler J., and Walker S.E. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. J. Neuroimmunol. 35 (1991) 89-99
63. Winfield J.B., Shaw M., Silverman L.M., Eisenberg R.A., Wilson III H.A., and Koffler D. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am. J. Med. 74 (1983) 837-844
64. Wolburg K., Gerhardt H., Schulz M., Wolburg H., and Engelhardt B. Ultrastructural localization of adhesion molecules in the healthy and inflamed choroid plexus of the mouse. Cell Tissue Res. 296 (1999) 259-269
65. Yoshio T., Hirata D., Onda K., Nara H., and Minota S. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus. J. Rheumatol. 32 (2005) 34-39
66. Zameer A., and Hoffman S.A. Immunoglobulin binding to brain in autoimmune mice. J. Neuroimmunol. 120 (2001) 10-18
67. Zameer A., and Hoffman S.A. Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice. J. Neuroimmunol. 142 (2003) 67-74
68. Zameer A., and Hoffman S.A. B and T cells in the brains of autoimmune mice. J. Neuroimmunol. 146 (2004) 133-139
69. Zhou G., Fujio K., Sadakata A., Okamoto A., Yu R., and Yamamoto K. Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice. Clin. Exp. Immunol. 136 (2004) 448-455